Company data
Sagimet Biosciences Inc. employees and revenue per employee
SGMT · Biotechnology · $333M market cap
Sagimet Biosciences Inc. had 10 employees at the end of fiscal Dec 2023. Revenue for the year was $2.0M, or $200K per employee.
The latest annual report we hold is more than two years old, so these numbers may be out of date.
Employees
10
Revenue
$2.0M
Revenue / employee
$200K
Peer median $455K
Rank in industry
82 of 111
Biotechnology
Headcount against revenue
Both lines start at 100 in the first year we hold, so you can see which one grew faster.
Only one fiscal year on file so far, so there is no trend to draw yet.
Sagimet Biosciences Inc. against similar companies
The closest industry peers by revenue, from Biotechnology.
| Company | Employees | Revenue | Revenue / employee | Shape |
|---|---|---|---|---|
| SGMT Sagimet Biosciences Inc. | 10 | $2.0M | $200K | — |
| CGON CG Oncology Inc. | 142 | $4.0M | $28K | Efficient growth |
| STTK Shattuck Labs, Inc. | 40 | $1.0M | $25K | Contracting |
| DNTH Dianthus Therapeutics, Inc. | 92 | $2.0M | $22K | Hiring into decline |
| ABSI Absci Corporation | 140 | $2.8M | $20K | Contracting |
| INBX Inhibrx Biosciences Inc. | 109 | $1.3M | $12K | Leaner |
| NGNE Neurogene Inc. | 107 | $925,000 | $9K | — |
| CLDX Celldex Therapeutics, Inc. | 198 | $1.5M | $8K | Hiring into decline |
| AKTS Aktis Oncology, Inc. | 200,000 | $6.5M | $32 | — |
Questions about Sagimet Biosciences Inc.
- How many employees does Sagimet Biosciences Inc. have?
- Sagimet Biosciences Inc. reported 10 employees for the fiscal year ending Dec 2023, in the annual report it filed on March 25, 2024.
- What is Sagimet Biosciences Inc.'s revenue per employee?
- Sagimet Biosciences Inc. brought in $2.0M of revenue in fiscal Dec 2023, which is $200K per employee. That ranks 82 of 111 companies we track in Biotechnology, where the median is $455K.
- Where do these numbers come from?
- Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.
Outpick research
This page is the filings. The research is a membership.
On the first and third Friday of each month Outpick publishes one stock pick with the full case for owning it, adds it to a live portfolio you can audit, and writes a note when a position closes. A new account gets 21 days of the whole membership with no card, and nothing is charged when it ends.
Free game
Think you can pick better than the S&P 500?
Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.
Enter the challengeMore data
Compare SGMT with the rest of the market
See who earns the most per employee, who is hiring, and who is cutting, across every company we track.
Source: employee counts and revenue as stated in Sagimet Biosciences Inc.'s annual reports (Form 10-K), latest filed March 25, 2024. This is data, not a recommendation to buy or sell SGMT.